Sublingual immunotherapy reduces further allergies in children with atopic dermatitis: Study Jacinthlyn Sylvia1 Aug 2022 10:00 AM ISTIn a new study conducted by Minju Kim and team, it was found that in children with atopic dermatitis who were also sensitive to dust mites, sublingual...
Study finds Acupuncture to reduce itch in patients with Atopic Dermatitis Jacinthlyn Sylvia28 July 2022 7:45 PM ISTIn a new study published in Clinical and Experimental Dermatology, acupuncture (ACU) has been shown to improve itching in people with atopic...
Tralokinumab and Topical Corticosteroids tied to sustained important in Atopic Dermatitis: ECZTRA 3 trial. Dr.Niharika Harsha B27 July 2022 7:00 PM ISTOver 32 weeks, it was found that continued use of tralokinumab treatment plus topical corticosteroids as needed provided progressive and sustained...
Sanofi gets CDSCO Panel okay to study Dupilumab Dr. Divya Colin19 July 2022 6:00 PM ISTNew Delhi: Directing to include all Serious Adverse Events (SAEs) and adverse events (AEs) of test drug in the informed consent document, the Subject...
Syngene, Zoetis ink pact to manufacture drug substance for Librela Ruchika Sharma16 July 2022 11:33 AM ISTMumbai: Syngene International Limited has recently announced the signing of a 10-year agreement with leading animal health company, Zoetis, to...
Dietary salt intake tied to risk of atopic dermatitis: Study Medha Baranwal11 July 2022 7:30 PM ISTUSA: A recent study found that dietary salt intake is associated with an increased atopic dermatitis (AD) risk and salt restriction could be offered...
Clinical Characteristics and Treatment of Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients Dr Ishan Kataria3 July 2022 8:00 PM ISTDupilumab has been approved by the Food and Drug Administration (FDA) to treat adults with moderate-to-severe atopic dermatitis (AD) that is...
FDA approves dupilumab for treatment of atopic dermatitis in pediatric patients Dr. Kamal Kant Kohli10 Jun 2022 9:00 AM ISTTARRYTOWN, N.Y. and PARIS: The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for children aged 6 months to 5 years with...
Sanofi Dupixent wins USFDA nod for atopic dermatitis Ruchika Sharma8 Jun 2022 1:00 PM ISTDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites.
Upadacitinib most effective oral JAK inhibitor for treating atopic dermatitis, study claims Medha Baranwal7 Jun 2022 11:00 AM ISTUSA: Janus kinase (JAK) inhibitors are an effective treatment for atopic dermatitis (AD) patients, according to results from a new systematic review....
Bleach baths may benefit patients with mild to severe atopic dermatitis Dr. Shravani Dali11 May 2022 11:00 AM ISTBleach baths may help patients with mild to severe atopic dermatitis, according to a recent study published in the Annals of Allergy, Asthma &...
Antioxidants safe and effective treatment option for atopic dermatitis patients Medha Baranwal9 May 2022 8:00 PM ISTChina: Antioxidants alone or when combined with oral vitamin D and topical vitamin B12 may be a safe and effective treatment for atopic dermatitis...
